Divi's Laboratories Ltd on Saturday reported a sharp 63.57 per cent rise in its net profit for the September quarter, touching ₹1,127 crore. According to a regulatory filing by the company, the growth in profitability was primarily supported by higher revenues during the period under review.
In the corresponding quarter of the previous fiscal year, the company had posted a net profit of ₹689 crore. Revenue from operations for the second quarter of the fiscal year saw a significant increase of 35.39 per cent, reaching ₹3,676 crore compared to ₹2,715 crore recorded in the same period a year earlier.
Alongside the growth in top-line revenue, the company's total expenses also saw an upward movement. Total expenses for the quarter rose to ₹2,265 crore, compared to ₹1,948 crore recorded during the corresponding period of the previous fiscal year.
Meanwhile, the company's financial performance for the first half of the current fiscal year presented a different trajectory. Divi's Laboratories reported a decline of 35.39 per cent in its net profit for the six-month period, dropping to ₹2,029 crore from ₹2,568 crore in the corresponding period of the previous year, as per the regulatory filing.
"The financial results from Divi's Laboratories highlight a strong recovery in quarterly performance, driven by a 35 per cent increase in operating revenue. While expenses have risen alongside top-line growth, a 63 per cent jump in net profit demonstrates effective margin management for the quarter. However, the decline in first-half profitability indicates that quarterly volatility remains a factor to watch closely in the broader business landscape." — Dr. Shishir Gupta, Founder & CEO, StartupLanes
Recent StartupLanes Articles
Browse through our 30 latest publications on venture capital, startups, and angel investing.